Samar Mahmoud Mohamed Elbahy
Lecturer
Nerve conduction velocity and electromyography study in children with transfusion-dependent beta-thalassemia
• 2024
Publication Information
Authors
Aliaa Mohammed Diab1, Elham Abdelghafar Nawar1, Shaimaa Alaa Mahmoud*1, Khaled M. Abdel Azim Eid2, Aziza Ibrahim Ali Ibrahim1, Samar Mahmoud Elbahy1
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Beta thalassemia is the most prevalent chronic hemolytic anemia with multiple recognized complications. Neuropathic changes have been recorded more frequently these days due to longer life expectancies. We conducted this work to evaluate the neurophysiological status of transfusion-dependent thalassemic children and to investigate the impact of different clinical factors and iron overload status on the findings.
Methods: We conducted a non-randomized convenient study including 50 beta thalassemic children on regular blood transfusion, in addition to iron chelation therapy. All participants underwent a comprehensive clinical assessment, laboratory tests, and neurophysiological studies; nerve conduction and electromyography studies. Data were collected, including the most recent cardiac and hepatic MRI findings.
Results: Out of the 50 children included, 12 patients (24%) had abnormal sensory nerve conduction (peripheral neuropathy), and all children had normal motor nerve conduction. Only four patients (8%) showed myopathic changes by electromyography. These changes were strongly correlated with hepatic iron overload.
Conclusions: Children with transfusion-dependent beta-thalassemia on regular iron chelation therapy are at risk of neurological changes, as peripheral neuropathy and myopathy, necessitating regular follow-up of these patients.
Methods: We conducted a non-randomized convenient study including 50 beta thalassemic children on regular blood transfusion, in addition to iron chelation therapy. All participants underwent a comprehensive clinical assessment, laboratory tests, and neurophysiological studies; nerve conduction and electromyography studies. Data were collected, including the most recent cardiac and hepatic MRI findings.
Results: Out of the 50 children included, 12 patients (24%) had abnormal sensory nerve conduction (peripheral neuropathy), and all children had normal motor nerve conduction. Only four patients (8%) showed myopathic changes by electromyography. These changes were strongly correlated with hepatic iron overload.
Conclusions: Children with transfusion-dependent beta-thalassemia on regular iron chelation therapy are at risk of neurological changes, as peripheral neuropathy and myopathy, necessitating regular follow-up of these patients.
